BioDech: A Global Life Sciences Broadcast Series
Latest Episode | Previous Episodes
In today's competitive landscape, life sciences companies routinely face a myriad of legal complexities and regulatory issues, from early-stage financing for clinical trials and IPO preparedness, to antitrust, securities or patent disputes post-product launch. Despite the challenges, innovation in the market is more active than ever.
To help companies navigate these issues, BioDech brings together life sciences industry leaders with lawyers from Dechert’s cross-practice global life sciences team to discuss the challenges and opportunities that may arise at every phase of the life sciences life cycle, from discovery through development, clinical testing, promotion and sales.
Latest Episode: Episode 5 – Executive Compensation Considerations for a Successful IPO
May 15, 2023 – Executive compensation plays a critical role in preparing for a successful IPO. In the fifth episode of BioDech, our global life sciences broadcast series, we discuss key considerations such as market assessment, identification of peer groups, competitive research, regulatory considerations and more.
Speakers:
Kevin Kay | Partner, Employee Benefits and Executive Compensation, Dechert
John Schultz | Managing Director, Co-head of Compensation and Benefits, Alvarez & Marsal
Brennan Rittenhouse | Managing Director, Alvarez & Marsal
About Dechert's Life Sciences Practice
Dechert’s life sciences group delivers industry expertise and commercial judgment to help leading life sciences companies navigate their most complex and demanding transactional, intellectual property and litigation matters. Our global multi-disciplinary team has the reach, resources and experience to provide comprehensive transactional, regulatory and dispute resolution services anywhere in the world. Learn more.
Related Professionals
